US Earnings Financial Results SEC Filings — May 21, 2026

21-05-2026

Barnwell Industries reported a net loss attributable to the company of $1.15M for Q2 FY2026 (three months ended March 31, 2026), narrowing from a $1.207M loss in the prior-year quarter. Revenue fell 29% to $2.535M, driven by a $1.06M decline in oil and natural gas sales. However, operating costs decreased 19% to $3.983M, and the company recorded a $338,000 equity in income of affiliates, partially offsetting the revenue drop. For the six-month period, the net loss attributable to Barnwell improved to $2.576M from $3.124M a year ago, though cash used in operations increased to $2.422M from $854M.

• · The company issued 926,403 shares of common stock, net of costs, during the six months ended March 31, 2026, raising $3.365M.
• · Cash used in operating activities from continuing operations increased to $2.422M in H1 FY2026 from $0.854M in H1 FY2025, a 184% increase.
• · Capital expenditures for oil and natural gas dropped sharply to $0.25M in H1 FY2026 from $2.641M in H1 FY2025.
• · The company recorded a $338,000 equity in income of affiliates in Q2 FY2026, compared to $0 in the prior-year quarter.
• · Accumulated deficit widened to $9.084M at March 31, 2026 from $6.508M at September 30, 2025.
• · Total liabilities decreased to $13.388M from $13.790M over the same period.
• · The company had no discontinued operations in FY2026; the prior-year period included a contract drilling segment that was sold.

21-05-2026

DALRADA TECHNOLOGY GROUP (DHTI) reported a net loss of $4.3M for the quarter ended March 31, 2026, roughly flat vs. a $4.2M loss in the same quarter last year, while total revenue declined 44% YoY to $2.6M. For the nine-month period, revenue fell 28% YoY to $9.9M, and the net loss improved 17% to $14.8M. The company continues to operate with negative stockholders' equity of -$20.9M and total current liabilities of $29.9M far exceed current assets of $8.0M, signaling acute liquidity risk.

• · Cash and cash equivalents fell 52% from $172.8K at June 30, 2025 to $82.6K at March 31, 2026.
• · Total liabilities increased 54% from $25.0M to $38.5M, driven by a surge in accounts payable and accrued liabilities – related parties (from $3.4M to $10.5M) and notes payable, current portion (from $3.9M to $9.1M).
• · Stockholders' deficit worsened from -$6.7M to -$20.8M, more than tripling.
• · Net cash used in operating activities for the nine months was $6.1M, roughly flat compared to $6.1M in the prior year period.
• · Interest expense for the nine months increased 9.8% to $2.6M from $2.4M, while interest income dropped 91.2% to $5.1K.
• · The company issued 14,206 shares of Series I preferred stock during Q1 FY2026 upon conversion of related party notes.
• · Approximately $11.9M of preferred stock to be issued was reclassified to additional paid-in capital during the second quarter.
• · Loss per share improved from -$0.19 to -$0.14 (basic and diluted) for the nine-month period.

21-05-2026

e.l.f. Beauty, Inc. reported a strong 24.6% YoY net sales increase to $1,636.5M for fiscal year 2026, with solid cash flow from operations of $212.5M. However, net income declined sharply by 76.5% to $26.3M due to a $57.6M non-cash charge from the change in fair value of contingent consideration, significant SG&A expense growth, and higher interest expense, resulting in a net profit margin compression from 9% to 2%.

• · Gross profit margin remained stable at 71% for all three fiscal years (2024-2026).
• · Interest expense more than doubled to $35.3M in fiscal 2026 from $13.8M in fiscal 2025.
• · Total assets nearly doubled to $2.39B from $1.25B, driven by goodwill ($853.5M) and intangible assets ($553.1M) from acquisitions.
• · Long-term debt increased to $809.3M from $256.7M, reflecting acquisition financing.
• · Total stockholders' equity rose to $1.13B from $760.9M, while accumulated deficit improved to $(155.9M) from $(182.2M).
• · Cash and cash equivalents increased to $289.7M from $148.7M.
• · Basic weighted average shares outstanding increased to 58.3M from 56.2M (3.7% dilution).
• · A $57.6M non-cash charge was recorded due to change in fair value of contingent consideration; this was not present in prior periods.

21-05-2026

Advance Auto Parts reported flat net income of $24M for the 16 weeks ended April 25, 2026, compared to $24M in the prior-year period, despite a 1.2% increase in net sales to $2,614M. Operating income improved significantly to $69M from a loss of $131M, driven by lower restructuring expenses and improved gross margin. However, cash flow from operations remained negative at -$19M, and the company's cash position declined by $167M to $2,956M.

• · Parts and Batteries sales mix increased to 64% of net sales from 62% in the prior year, while Accessories and Chemicals declined to 21% from 23%.
• · Interest expense more than doubled to $65M from $27M in the prior period.
• · Net cash used in investing activities increased to $112M from $27M, including $55M from discontinued operations.
• · Dividends paid doubled to $30M from $15M in the prior period.
• · The company repurchased $8M of common stock in the current period versus $2M in the prior period.
• · Cash dividends declared were $0.25 per common share, consistent with the prior period.

21-05-2026

Applied Materials reported strong financial results for the six months ended April 26, 2026, with net income of $4,832M, up 45.5% from $3,322M in the prior-year period. Diluted EPS rose to $6.05 from $4.08, a 48.3% increase. However, cash provided by operating activities grew only modestly to $2,531M from $2,496M, and the company's cash and cash equivalents balance declined by $953M during the period, driven by significant investing and financing outflows.

• · Total stockholders' equity increased to $23,909M at April 26, 2026 from $20,415M at October 26, 2025.
• · Retained earnings grew to $59,274M from $55,227M over the six-month period.
• · Treasury stock repurchases totaled $737M in the six months ended April 26, 2026, down sharply from $2,999M in the prior-year period.
• · Cash used in investing activities was $1,739M, up from $676M in the prior-year period, driven by higher capital expenditures and acquisition spending.
• · Cash used in financing activities was $1,745M, compared to $3,689M in the prior-year period, reflecting lower share repurchases.
• · Total investments (short-term and long-term) had an estimated fair value of $7,082M at April 26, 2026, including $2,248M in publicly traded equity securities and $379M in privately held equity investments.
• · The company reported a $1,138M gain on investments in the six months ended April 26, 2026, versus a $24M loss in the prior-year period.
• · Cash payments for income taxes were $650M, down from $833M in the prior-year period.
• · The company had no potentially dilutive securities excluded from the diluted EPS calculation.

21-05-2026

Hemab Therapeutics reported a net loss of $22.7M for Q1 2026, widening from $15.3M in Q1 2025, driven by a 43% increase in operating expenses to $23.6M. Cash and cash equivalents fell sharply to $49.9M from $88.0M at year-end 2025, while total assets decreased to $175.3M from $194.8M. The company completed a reorganization that converted all convertible preference shares into convertible preferred stock, and its accumulated deficit grew to $204.5M.

• · Net loss per share for Q1 2026 was $(23.98), compared to $(16.18) in Q1 2025.
• · Total comprehensive loss for Q1 2026 was $(23.3M), compared to $(14.3M) in Q1 2025.
• · Net cash used in operating activities increased to $21.6M in Q1 2026 from $13.0M in Q1 2025.
• · Net cash used in investing activities was $15.8M in Q1 2026, up from $6.0M in Q1 2025.
• · Equity-based compensation rose to $1.3M in Q1 2026 from $0.5M in Q1 2025.
• · The company had $2.3M in deferred offering costs included in accrued expenses and accounts payable as of March 31, 2026.
• · Marketable securities consisted entirely of Level 2 assets: $98.3M in U.S. treasury securities and $15.4M in non-U.S. debt securities as of March 31, 2026.
• · The company completed a reorganization during Q1 2026, converting all convertible preference shares into convertible preferred stock and eliminating ordinary shares.
• · Total stockholders' deficit worsened to $(198.6M) as of March 31, 2026 from $(176.6M) as of December 31, 2025.
• · Total liabilities increased to $13.7M from $11.3M over the same period.

21-05-2026

Alchemy Investments Acquisition Corp 1 reported a net loss of $331,900 for Q1 2026, widening from a $301,497 loss in Q1 2025, driven by higher interest expense and lower investment gains. Operating costs decreased slightly to $362,994 from $401,439, but total other income fell to $31,094 from $99,942. The company's cash position improved to $86,243 from $55,020 at year-end 2025, though it remains dependent on related-party financing, with a promissory note balance of $2,000,000.

• · Total liabilities increased to $9,259,816 as of March 31, 2026 from $8,688,322 at December 31, 2025.
• · Shareholders' deficit worsened to $(8,985,142) from $(8,509,049) over the same period.
• · Net cash used in operating activities improved to $(192,399) in Q1 2026 from $(369,175) in Q1 2025.
• · Proceeds from related-party promissory notes were $290,000 in Q1 2026, down from $600,000 in Q1 2025.
• · Remeasurement of redeemable Class A ordinary shares to redemption amount was $144,193 in Q1 2026, compared to $274,408 in Q1 2025.
• · Deferred underwriting fee payable remained unchanged at $5,175,000.

21-05-2026

Flowers Foods reported mixed Q1 FY2026 results for the sixteen weeks ended April 25, 2026. Net sales increased 1.1% YoY to $1.57B, but net income declined 20.6% to $42.1M, with diluted EPS falling from $0.25 to $0.20. Operating income decreased 6.3% to $79.8M, while cash from operations dropped 20.5% to $107.9M. The company continued share repurchases and increased dividends.

• · Total assets decreased slightly from $4.184B on Jan 3, 2026 to $4.181B on Apr 25, 2026.
• · Total stockholders' equity remained nearly flat at $1.302B vs $1.303B.
• · Restructuring charges increased to $1.652M from $0.573M in the prior year period.
• · Interest expense rose 25.4% YoY to $24.7M, driven by higher debt levels.
• · The company had no plant closure costs or asset impairments in the current period, compared to $7.4M in the prior year.
• · Goodwill decreased slightly from $1.0478B to $1.0471B.
• · Cash and cash equivalents declined from $12.1M to $11.5M.
• · The company repurchased 378,398 shares for $3.8M during the period.
• · Dividends paid increased to $54.4M from $52.3M in the prior year.

21-05-2026

Agilysys Inc. reported total net revenue of $319.3M for the fiscal year ended March 31, 2026, a 15.9% increase from $275.6M in the prior year, driven by strong growth in subscription and maintenance revenue (+21.1%) and professional services (+12.4%). However, product revenue declined slightly by 0.4% to $41.2M, and operating income surged 90.4% to $43.0M, while the effective tax rate jumped to 19.9% from 9.4%, significantly increasing the income tax provision.

• · Product development expenses increased 16.6% to $72.7M in FY2026, while sales and marketing expenses grew 20.0% to $39.8M.
• · General and administrative expenses rose only 3.4% to $42.2M in FY2026.
• · Amortization of internal-use software and intangibles surged 48.9% to $5.7M in FY2026.
• · Other (gains) charges, net swung to a gain of $7.7M in FY2026 from a charge of $4.6M in FY2025.
• · Legal settlements, net decreased 68.4% to $0.3M in FY2026.
• · In FY2025, amortization of internal-use software and intangibles increased 182.5% to $3.9M, and other charges, net increased 163.6% to $4.6M.
• · Interest income declined 47.3% to $2.0M in FY2026, while interest expense decreased 67.8% to $0.5M.
• · Other income, net jumped 392.3% to $3.9M in FY2026.
• · Income tax provision increased 299.0% to $9.6M in FY2026, with the effective tax rate rising to 19.9% from 9.4%.
• · In FY2025, total other income (expense), net decreased 38.3% to $3.0M.
• · Joe Youssef joined as Chief Commercial Officer & Senior Vice President of Sales - Americas & EMEA in August 2024 and became an executive officer in 2025.

21-05-2026

Cirrus Logic reported strong financial results for fiscal year 2026, with net sales increasing 5.3% YoY to $1,997.4M and net income rising 25.0% to $414.4M, driven by improved gross margins and operating leverage. However, the company experienced a decline in inventories (down 19.5% to $240.9M) and a reduction in diluted EPS growth to $7.85 from $6.00, while cash flow from operations surged 46.4% to $650.6M.

• · Operating income margin improved to 23% in FY2026 from 22% in FY2025 and 19% in FY2024.
• · Net cash provided by operating activities increased 46.4% to $650.6M in FY2026 from $444.4M in FY2025.
• · The company repurchased $280.0M of common stock in FY2026, up from $261.0M in FY2025.
• · Cash and cash equivalents rose 48.5% to $800.9M at year-end.
• · Inventories decreased 19.5% to $240.9M, reflecting improved inventory management.
• · Prepaid wafers declined sharply from $52.6M to $14.7M (current) and from $15.5M to $0 (long-term).
• · Total assets grew 7.0% to $2,489.4M.
• · Stockholders' equity increased 9.2% to $2,128.0M.
• · The effective tax rate decreased to 16.6% in FY2026 from 25.5% in FY2025.
• · Basic weighted average shares outstanding declined 3.8% to 51.1M due to share repurchases.

21-05-2026

Hamilton Lane Incorporated reported net income attributable to the company of $249.2M for the fiscal year ended March 31, 2026, up 14.6% from $217.4M in FY2025, driven by strong growth in management and advisory fees (+13.7% to $584.2M) and a surge in consolidated fund net gains. However, total incentive fees declined 14.0% to $170.6M, primarily due to a sharp drop in specialized fund incentive fees (-19.7% to $146.3M). Adjusted EBITDA grew 11.4% to $407.6M, and non-GAAP EPS rose to $5.90 from $5.04.

• · Advisory fees declined 10.2% YoY to $20.5M.
• · Distribution management fees fell 17.1% YoY to $2.2M.
• · Non-operating gain (loss), net decreased 70.8% YoY to $2.5M.
• · Income attributable to non-controlling interests in Consolidated Funds and Partnerships surged to $44.2M from $3.5M, a 12.6x increase.
• · Net cash used in investing activities increased to $494.8M from $117.6M, a 320.7% rise.
• · Fee related performance revenues jumped 72.0% to $102.5M.
• · Equity-based compensation rose 62.0% to $50.9M.

21-05-2026

LiveRamp Holdings, Inc. reported a strong turnaround for the fiscal year ended March 31, 2026, with revenues increasing 9% YoY to $812.9M and net income from continuing operations of $144.8M compared to a net loss of $2.5M in the prior year. Subscription revenue grew 8% to $614.4M, while Marketplace and Other revenue rose 12% to $198.6M. However, gross margin slightly declined from 71.0% to 70.7%, and total other income decreased 16% to $14.6M.

• · The company's subscription net retention rate improved from 104% to 107% year-over-year.
• · Annualized recurring revenue grew 8% to $545M as of March 31, 2026.
• · Remaining performance obligation increased 7% to $760M, while current remaining performance obligation grew 10% to $518M.
• · Total operating expenses decreased 6% to $491.4M, driven by a 16% reduction in R&D and a 4% reduction in sales and marketing, partially offset by a 5% increase in G&A.
• · Income tax benefit of $46.7M was recorded in FY2026 versus an expense of $25.3M in FY2025.
• · Diluted earnings per share from continuing operations was $2.23, compared to a loss of $0.04 in the prior year.

21-05-2026

Microchip Technology Inc. filed its Form 10-K for the fiscal year ended March 31, 2026, reporting total net sales of $4,713.1 million, up 7.1% from $4,401.6 million in fiscal 2025. Gross profit margin improved to 57.7% from 56.1%, and operating income rose to 10.4% of sales from 6.7%. However, the company reported a total net loss of $80.3 million for fiscal 2026, compared to a net loss of $192.0 million in the prior year, driven by significant intercompany losses from non-guarantors.

• · The company's total assets decreased 4.5% to $9,725.0 million from $10,181.1 million, while total liabilities increased 1.6% to $15,353.7 million.
• · Long-term debt was reduced slightly to $5,496.4 million from $5,630.4 million.
• · Intercompany receivables from non-guarantors rose to $3,579.0 million from $3,527.3 million, and intercompany payables due to non-guarantors increased to $6,583.8 million from $6,095.1 million.
• · Revenue from non-guarantors declined sharply to $250.3 million from $400.2 million, while gross loss from non-guarantors widened to $415.3 million from $378.9 million.
• · Net loss from non-guarantors increased to $429.2 million from $402.8 million.
• · The company's largest facility is the Gresham, Oregon wafer fabrication plant (826,500 sq ft), followed by Chandler, Arizona (720,000 sq ft).
• · The independent registered public accounting firm is identified by PCAOB ID 42.

21-05-2026

Logitech International S.A. reported a 6% increase in net sales to $4.84B for the fiscal year ended March 31, 2026, with gross profit up 7% to $2.09B and gross margin slightly improving to 43.2%. However, the Americas region saw a 1% sales decline, and the 'Other' product category dropped 20% year-over-year. The effective tax rate rose sharply to 14.0% from 10.7%, and accounts payable days outstanding increased significantly to 79 from 65.

• · Gaming segment grew 6% YoY to $1.41B, Keyboards & Combos up 6% to $937.6M, Pointing Devices up 9% to $858.9M, Video Collaboration up 10% to $689.0M, Webcams up 3% to $326.2M, Tablet Accessories up 12% to $336.2M.
• · Headsets sales were flat at $179.8M.
• · Operating expenses as a percentage of sales improved to 27.2% from 28.7%.
• · Marketing and selling expenses were $816.6M (16.9% of sales vs 17.9% prior), R&D $316.2M (6.5% vs 6.8%), G&A $167.2M (3.5% vs 3.6%).
• · Restructuring charges were $9.9M (0.2% of sales).
• · Accounts receivable increased to $505.9M from $454.5M; accounts payable rose to $531.0M from $414.6M; inventories decreased to $489.9M from $503.7M.
• · DSO increased to 42 days from 40; DPO increased to 79 days from 65; ITO improved to 4.9x from 4.6x.
• · Share repurchases in FY2026 totaled 6,167 shares at a weighted average price of CHF 71.58 / $90.23, with $91,822 remaining under the program.
• · In Q4 FY2026, 3,489 shares were repurchased at a weighted average price of CHF 70.79, all on SIX Swiss Exchange.

21-05-2026

Apple iSports Group, Inc. reported a net loss of $385,221 for Q1 2026, a significant improvement from the $3,191,732 loss in Q1 2025, driven by a sharp reduction in consulting and professional fees. However, the company still has zero revenue, its cash position collapsed from $55,938 to just $860, and total stockholders' deficit widened to $4,385,268 from $4,061,454, indicating severe liquidity constraints.

• · Zero net revenues for both Q1 2026 and Q1 2025.
• · Total current liabilities of $6,776,777 exceed total assets of $2,391,509, resulting in negative working capital.
• · Accumulated deficit increased to $20,051,879 from $19,666,658.
• · Foreign currency translation adjustment loss of $188,593 in Q1 2026 vs $10,731 in Q1 2025.
• · Related party loans payable increased to $2,430,764 from $2,261,484.
• · Deferred financing costs (current and non-current) total $2,295,042, representing a significant asset relative to cash.
• · Stock options outstanding increased from 8,275,000 to 9,275,000 (Series 2) during Q1 2026.
• · Intrinsic value of outstanding options declined from $3,144,500 to $1,670,428 (Series 2) and from $760,000 to $360,200 (Series 1).

21-05-2026

Allegro MicroSystems reported a significant improvement in its fiscal year 2026 results, with total net sales increasing 22.8% YoY to $890.1 million, driven by strong growth in both Automotive (+17.4%) and Industrial and other (+37.8%) segments. The company swung to an operating income of $18.5 million from an operating loss of $19.8 million in the prior year. However, the company still reported a net loss attributable to Allegro of $14.9 million, though this was a substantial improvement from the $73.0 million net loss in fiscal 2025.

• · Gross margin improved to 46.3% in fiscal 2026 from 44.3% in fiscal 2025.
• · Research and development expenses increased 14.6% to $205.8 million, representing 23.1% of net sales.
• · Selling, general and administrative expenses increased 12.0% to $181.1 million, representing 20.3% of net sales.
• · The company recorded a $6.6 million impairment of assets held for sale in fiscal 2026.
• · Interest expense decreased 27.1% to $22.1 million.
• · Loss in earnings of equity investment was $9.4 million in fiscal 2026, compared to income of $1.2 million in fiscal 2025.
• · Net cash used in financing activities was $77.4 million, down from $112.1 million in the prior year.
• · The company's net loss before income taxes improved to $14.9 million from $85.7 million.
• · Income tax benefit decreased to $0.2 million from $12.9 million.
• · Greater China sales grew 36.3% to $249.4 million, while Other Asia sales surged 74.8% to $158.0 million.

21-05-2026

Nordson Corp reported Q2 FY2026 sales of $740.8M, up 8.5% YoY from $682.9M, and net income of $117.3M, up 4.4% from $112.4M. For the six months, sales grew 8.6% to $1.41B and net income rose 21.1% to $250.7M. However, operating cash flow increased 15.4% to $321.1M, while cash and equivalents declined 5.9% to $102.0M from Oct 2025. The company also recorded a $24.0M pension settlement charge in Q2.

• · Diluted EPS for Q2 FY2026 was $2.09, up from $1.97 in Q2 FY2025.
• · Six-month diluted EPS was $4.47, up from $3.62 in the prior year period.
• · Gross margin for Q2 FY2026 was 54.5% (sales $740.8M, cost of sales $336.8M), compared to 54.7% in Q2 FY2025.
• · Selling and administrative expenses increased 0.8% YoY in Q2 to $206.9M.
• · Interest expense decreased 17.4% YoY in Q2 to $21.9M.
• · The company repurchased $129.3M of treasury shares in the first six months of FY2026, compared to $146.3M in the prior year period.
• · Dividends declared were $0.82 per share in FY2026, up from $0.78 in FY2025.
• · Total assets increased to $5.96B at April 30, 2026 from $5.92B at October 31, 2025.
• · Long-term debt increased to $1.84B from $1.68B, while current maturities decreased to $50M from $315M.
• · Goodwill increased to $3.33B from $3.30B, and intangible assets net decreased to $651.0M from $681.6M.

21-05-2026

Ralph Lauren Corp reported strong fiscal 2026 results with net revenues increasing 14.6% to $8,114.5M and net income rising 26.7% to $941.1M. However, cash flow from operations declined 6.6% to $1,154.2M, and net cash and short-term investments decreased 12.2% to $826.1M due to increased debt and investing activities.

• · Gross margin improved 130 bps to 69.9% in fiscal 2026 from 68.6% in fiscal 2025.
• · SG&A expenses increased 13.2% to $4,371.9M, driven by compensation-related expenses ($166.5M) and marketing ($118.4M).
• · Restructuring and other charges more than doubled to $118.1M from $57.8M.
• · Segment operating income: North America $724.2M (margin 21.8%), Europe $704.6M (27.8%), Asia $577.2M (27.4%).
• · Long-term debt increased to $1,238.9M from $742.9M, while current portion of long-term debt was zero vs $399.7M.
• · Net cash used in investing activities was $356.6M, up from $264.1M.
• · Net cash used in financing activities was $769.7M, up from $704.0M.
• · Total contractual obligations as of March 28, 2026: $4,915.5M, including $1,250M in senior notes due fiscal 2030-2032+.

21-05-2026

Thermon Group Holdings, Inc. reported sales of $536.3M for fiscal year 2026, an 8% increase from $498.2M in FY2025, driven by gross margin expansion to 45.3%. However, net income declined 17% to $44.6M from $53.5M, as selling, general and administrative expenses surged 22% and the effective tax rate rose to 30.6% from 23.7%. Adjusted EBITDA grew 9% to $119.6M, and adjusted diluted EPS increased 15% to $2.15, but free cash flow fell 38% to $32.9M.

• · Total assets increased to $830.6M as of March 31, 2026 from $755.5M a year earlier.
• · Total equity rose to $538.7M from $495.3M.
• · Cash and cash equivalents grew to $52.3M from $39.5M.
• · Inventories increased to $118.1M from $89.0M.
• · Goodwill stood at $269.0M, up from $264.3M.
• · Total debt (current portion + revolver + long-term) was $141.1M as of March 31, 2026, compared to $138.4M a year earlier.
• · The company repurchased shares, with treasury stock increasing to $36.2M from $20.4M.
• · Transaction-related costs in FY2026 were $12.9M, up from $0.4M in FY2025.
• · ERP implementation-related costs were $1.9M in FY2026 versus $0.6M in FY2025.
• · Depreciation and amortization was $22.5M in FY2026, relatively flat versus $22.3M in FY2025.

21-05-2026

Naploy Corp. reported a net loss of $476 for the three months ended April 30, 2026, a significant improvement from a net loss of $3,812 in the same period last year. However, the company continues to operate with a stockholders' deficit of $19,912 and an accumulated deficit of $56,179 as of April 30, 2026. While revenues increased substantially to $4,996 from $1,653 in the prior-year quarter, operating expenses remained high, and the company has no income tax provision due to a full valuation allowance on deferred tax assets.

• · Total operating expenses for the three months ended April 30, 2026 were $5,472, nearly unchanged from $5,465 in the prior-year quarter.
• · Amortization expense remained flat at $2,250 per quarter and $6,750 for the nine-month periods.
• · General and administrative expenses increased to $25 for the quarter from $19, but decreased to $63 for the nine-month period from $69.
• · Professional fees were $3,197 for the quarter (vs. $3,196) and $15,100 for the nine-month period (vs. $14,855).
• · The company had no income tax provision for any period due to a full valuation allowance on deferred tax assets.
• · Net loss per share (basic and diluted) was $0.00 for all periods presented.
• · Cash flows from operating activities turned positive at $2,837 for the nine months ended April 30, 2026, compared to a use of $23,524 in the prior period.
• · Cash flows from financing activities were $162 (related party loans) vs. $1,537 (including $1,375 from stock sales) in the prior period.
• · Total assets decreased to $55,591 from $59,342, primarily due to amortization of intangible assets.
• · Total current liabilities increased to $75,503 from $70,470, driven by a rise in deferred revenue and related party payables.
• · The company's accumulated deficit grew to $56,179 from $47,395, and stockholders' deficit widened to $19,912 from $11,128.

21-05-2026

Advanced Drainage Systems reported FY2026 net sales of $3.05B, up 5.0% YoY from $2.904B, and net income attributable to ADS of $426.5M, down 5.2% from $450.2M in FY2025. Gross profit increased 6.7% YoY to $1.167B, while operating income fell to $619.2M from $657.4M. Adjusted EBITDA rose to $962.9M (31.6% margin), an 8.3% increase from $889.2M (30.6% margin) in the prior year. However, net income has declined for two consecutive years from $509.9M in FY2024, and the Stormwater segment gross profit declined 10.1% in FY2025 before recovering 5.3% in FY2026. SG&A expenses rose sharply to 15.4% of sales from 13.1% due to restructuring, realignment, and transaction costs totaling $89.1M.

• · Restructuring and realignment expense in FY2026 was $48.3M (none in FY2025).
• · Transaction costs increased to $40.8M in FY2026 from $9.3M in FY2025, largely related to the NDS acquisition.
• · Loss on disposal of assets and costs from exit/disposal activities were $19.2M in FY2026 vs $3.9M in FY2025.
• · Interest expense grew to $93.9M in FY2026 from $91.8M in FY2025.
• · Depreciation and amortization increased to $216.3M in FY2026 from $183.3M in FY2025.
• · Cash flow from operations improved sharply to $819.1M in FY2026 from $581.5M in FY2025.
• · Capital expenditures rose to $249.8M in FY2026 from $212.9M in FY2025.
• · Inventory step-up related to NDS acquisition was $12.3M in FY2026.
• · Net loss from discontinued operations was $1.09M in FY2026, with no discontinued operations in FY2025.
• · FY2024 net income attributable to ADS was $509.9M — the current year is 16.4% lower than two years prior.
• · Adjusted EBITDA margin for FY2026 was 31.6%, up from 30.6% in FY2025 but down from 32.1% in FY2024.
• · Stormwater segment gross profit declined 10.1% in FY2025 before recovering 5.3% in FY2026.

21-05-2026

Gen Digital Inc. reported strong fiscal 2026 results with net revenues increasing 27% YoY to $5,000M, driven by a 119% surge in Trust-Based Solutions to $1,661M. Net income rose 51% to $973M, and operating income grew 32% to $2,120M. However, cost of revenues increased 39% to $1,077M, sales and marketing expenses jumped 65% to $1,228M, and cash and equivalents dropped 59% to $411M, signaling higher spending and reduced liquidity.

• · Net income per share (diluted) increased from $1.03 in FY2025 to $1.57 in FY2026.
• · Gross profit margin declined from 80% in FY2025 to 78% in FY2026.
• · Interest expense improved slightly from $(578)M to $(569)M, a $9M decrease.
• · Non-operating expense net worsened from $(581)M to $(609)M, driven by a $49M increase in change in fair value and impairment of non-marketable equity investments.
• · Effective tax rate decreased from 38% to 36%.
• · Restructuring and other costs surged 400% from $7M to $35M.
• · Impairment of intangible assets was $0 in FY2026 versus $3M in FY2025.